Nothing Special   »   [go: up one dir, main page]

Moore et al., 2023 - Google Patents

Anti-Inflammatory Effects of Peripheral Dopamine

Moore et al., 2023

View HTML
Document ID
10328154707005560822
Author
Moore S
Vaz de Castro P
Yaqub D
Jose P
Armando I
Publication year
Publication venue
International Journal of Molecular Sciences

External Links

Snippet

Dopamine is synthesized in the nervous system where it acts as a neurotransmitter. Dopamine is also synthesized in a number of peripheral organs as well as in several types of cells and has organ-specific functions and, as demonstrated more recently, is involved in …
Continue reading at www.mdpi.com (HTML) (other versions)

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof

Similar Documents

Publication Publication Date Title
Carli et al. Atypical antipsychotics and metabolic syndrome: from molecular mechanisms to clinical differences
Liu et al. The role of transient receptor potential melastatin 7 (TRPM7) in cell viability: a potential target to suppress breast cancer cell cycle
Dakroub et al. Visfatin: A possible role in cardiovasculo-metabolic disorders
Adolph et al. Adipokines and non-alcoholic fatty liver disease: multiple interactions
Krstic et al. p53 as a dichotomous regulator of liver disease: the dose makes the medicine
Dabravolski et al. The role of mitochondrial mutations and chronic inflammation in diabetes
Moore et al. Anti-Inflammatory Effects of Peripheral Dopamine
Liang et al. The mechanisms of the development of atherosclerosis in prediabetes
Chen et al. Identifying therapeutic targets for spinocerebellar ataxia type 3/Machado–Joseph disease through integration of pathological biomarkers and therapeutic strategies
Dardis et al. Molecular genetics of Niemann–Pick Type C disease in Italy: an update on 105 patients and description of 18 NPC1 novel variants
Kahoul et al. Emerging roles for the INK4a/ARF (CDKN2A) locus in adipose tissue: implications for obesity and type 2 diabetes
Machin et al. Rho family GTPases and rho GEFs in glucose homeostasis
Heydari et al. Data on adiponectin from 2010 to 2020: therapeutic target and prognostic factor for liver diseases?
Jeong et al. Spexin regulates hypothalamic leptin action on feeding behavior
Khajehlandi et al. Endurance training regulates expression of some angiogenesis-related genes in cardiac tissue of experimentally induced diabetic rats
Jian et al. Aerobic exercise alleviates abnormal autophagy in brain cells of APP/PS1 mice by upregulating AdipoR1 levels
Mietelska-Porowska et al. Induction of brain insulin resistance and Alzheimer’s molecular changes by western diet
Wagner et al. Adjusting the molecular clock: the importance of circadian rhythms in the development of glioblastomas and its intervention as a therapeutic strategy
Ivanoshchuk et al. Analysis of APPL1 gene polymorphisms in patients with a phenotype of maturity onset diabetes of the young
Rutkowska et al. Familial partial lipodystrophy—literature review and report of a novel variant in pparg expanding the spectrum of disease-causing alterations in FPLD3
Kang et al. A novel aryl hydrocarbon receptor antagonist HBU651 ameliorates peripheral and hypothalamic inflammation in high-fat diet-induced obese mice
Kim et al. Altered differentiation of tendon-derived stem cells in diabetic conditions mediated by macrophage migration inhibitory factor
Banskota et al. Inhibition of nadph oxidase (NOX) 2 mitigates colitis in mice with impaired macrophage AMPK function
Guo et al. Mutant LRP6 impairs endothelial cell functions associated with familial normolipidemic coronary artery disease
Ji et al. Activating PPARβ/δ protects against endoplasmic reticulum stress-induced astrocytic apoptosis via UCP2-dependent mitophagy in depressive model